Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: win-ratio reanalysis of the TRANSFORM-HF trial

The authors aimed to evaluate the comparative effectiveness of torsemide versus furosemide in managing heart failure patients, specifically assessing outcomes related to mortality, hospitalizations, and patient-reported health status using a hierarchical win-ratio framework. Their analysis of the TRANSFORM-HF trial data revealed no significant differences between the two diuretics over a 12-month period, suggesting that neither treatment demonstrated superiority in improving patient outcomes. The findings are considered exploratory and highlight the need for further research in this area.